CLOCK and neoplasm: A growing body of evidence is reporting that the circadian clock is dysregulated in PDAC, leading to different mechanisms of carcinogenesis, tumor growth, metastasis, and therapy resistance, making them ideal to act as potential biomarkers [30,31].